What If your R&D partner Could Do More? Cilcare Takes Therapy Development for ear disorders combining Deep preclinical lab expertise with Data Science and Clinical strategy
Time: 12:45 pm
day: Day 1
Details:
• Unrivaled Preclinical Expertise in Hearing Disorders
• Cilcare offers a unique scientific platform dedicated to ear disorders, mastering in vitro,
explant, and in vivo models, along with microsurgery, electrophysiology, and histology
techniques—providing translational insights few service providers can match.
• Beyond Testing: Strategic Integration of Data & Clinical Vision
• Cilcare combines robust lab science with data science and clinical development insight
to guide target selection, de-risk programs early, and support smarter therapeutic
positioning in a complex regulatory landscape.
• From Models to Patients: Translational Value Through Clinical Programs Through clinical
studies such as SAPHIR and DIAMANT, Cilcare bridges the gap between auditory and
neuroinflammatory disorders, using Target Product Profiles (TPPs) to design clinically
relevant, outcome-driven protocols — exemplified by our lead drug candidate, CIL001.